Laurion Capital Management LP Alkermes Plc. Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$13.06 - $21.24 $148,635 - $241,732	-11,381 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$17.29 - $21.74 $196,777 - $247,422	11,381 New	11,381 $232,000
Q3 2019 Nov 13, 2019	SELL	$19.51 - $24.28 $289,235 - $359,951	-14,825 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$21.47 - $37.33 $765,448 - $1.33 Million	-35,652 Reduced 70.63%	14,825 $334,000
Q1 2019 May 08, 2019	BUY	$28.4 - $36.49 $1.43 Million - $1.84 Million	50,477 New	50,477 $1.84 Million

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.